Suppr超能文献

高剂量丁丙诺啡在妊娠合并阿片类药物使用障碍管理中的应用。

High-Dose Buprenorphine Initiation in the Management of Opioid Use Disorder in Pregnancy.

机构信息

Division of Maternal-Fetal Medicine and the Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, Ohio.

出版信息

Obstet Gynecol. 2024 Jun 1;143(6):815-818. doi: 10.1097/AOG.0000000000005572. Epub 2024 Apr 4.

Abstract

Buprenorphine is commonly used as a treatment for opioid use disorder (OUD). Transition to buprenorphine traditionally has been done using a low-dose initiation regimen due to concerns surrounding precipitated withdrawal. There are increasing data supporting use of a high-dose initiation regimen in the nonpregnant population. This retrospective case series describes six individuals with OUD who underwent high-dose buprenorphine initiation in pregnancy. There were no instances of sedation, respiratory depression, supplemental oxygen use, or death. All individuals were successfully transitioned to buprenorphine. These findings provide support for high-dose buprenorphine initiation in pregnancy, but future large studies are needed.

摘要

丁丙诺啡通常被用作阿片类药物使用障碍(OUD)的治疗方法。由于担心引发戒断,传统上采用低剂量起始方案来过渡到丁丙诺啡。越来越多的数据支持在非孕妇人群中使用高剂量起始方案。本回顾性病例系列描述了 6 例在妊娠期间接受高剂量丁丙诺啡起始治疗的 OUD 患者。没有镇静、呼吸抑制、使用补充氧气或死亡的情况。所有患者均成功过渡到丁丙诺啡。这些发现为妊娠期间高剂量丁丙诺啡起始提供了支持,但需要进一步开展大型研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验